Filtros de búsqueda

Lista de obras de David G. Maloney

166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trials ⬇️

artículo científico publicado el 1 de octubre de 2003

90Y-ibritumomab tiuxetan therapy in allogeneic transplantation in B-cell lymphoma with extensive marrow involvement and chronic lymphocytic leukemia: utility of pretransplantation biodistribution

artículo científico publicado en 2014

A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group Protocol S9911 ⬇️

artículo científico publicado el 8 de mayo de 2003

A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation

artículo científico publicado en 2014

Absence of Replication-Competent Lentivirus in the Clinic: Analysis of Infused T Cell Products

artículo científico publicado en 2017

Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy

artículo científico publicado en 2016

Acute renal failure after nonmyeloablative hematopoietic cell transplantation

artículo científico publicado en 2004

Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning

artículo científico publicado en 2003

Adoptive therapy with chimeric antigen receptor-modified T cells of defined subset composition

artículo científico

Agranulocytosis unresponsive to growth factors following rituximab in vivo purging ⬇️

artículo científico publicado el 15 de mayo de 2003

Allogeneic haematopoietic cell transplantation after nonmyeloablative conditioning in patients with T-cell and natural killer-cell lymphomas

artículo científico publicado en 2010

Allogeneic hematopoietic cell transplant for patients with end stage renal disease requiring dialysis - a single institution experience

artículo científico publicado en 2016

Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma

artículo científico publicado en 2004

Allogeneic hematopoietic cell transplantation following minimal intensity conditioning: predicting acute graft-versus-host disease and graft-versus-tumor effects

artículo científico publicado en 2013

Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades

artículo científico publicado en 2020

Allografting after nonmyeloablative conditioning as a treatment after a failed conventional hematopoietic cell transplant ⬇️

artículo científico publicado el 1 de abril de 2003

Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma

artículo científico publicado en 2003

Anti-CD20 Antibody Therapy for B-Cell Lymphomas ⬇️

artículo científico publicado el 24 de mayo de 2012

Anti-HLA antibodies in recipients of CD19 versus BCMA-targeted CAR T-cell therapy

artículo científico publicado en 2023

Antibody-directed therapies for hematological malignancies

artículo científico publicado en 2002

Association between Calcineurin Inhibitor Blood Concentrations and Outcomes after Allogeneic Hematopoietic Cell Transplantation ⬇️

artículo científico publicado el 26 de agosto de 2011

Autologous and allogeneic transplantation for burkitt lymphoma outcomes and changes in utilization: a report from the center for international blood and marrow transplant research

artículo científico publicado en 2012

Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement

artículo científico publicado en 2013

Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial ⬇️

artículo científico publicado el 29 de septiembre de 2011

Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality

artículo científico publicado en 2013

Autologous transplant for relapsed follicular lymphoma: impact of pre-transplant rituximab sensitivity

artículo científico publicado en 2014

Beyond RCHOP: A Blueprint for Diffuse Large B Cell Lymphoma Research

artículo científico publicado en 2016

CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients

artículo científico publicado en 2016

CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results ⬇️

artículo científico publicado el 3 de febrero de 2012

Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance

article by Michael M Boyiadzis et al published 4 December 2018 in Journal for Immunotherapy of Cancer

Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation

artículo científico publicado en 2018

Clinical trials of CD19-targeted CAR-modified T cell therapy; a complex and varied landscape

artículo científico publicado en 2016

Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)-an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Tran

scientific article published on 15 May 2019

Comorbidities, Alcohol Use Disorder, and Age Predict Outcomes after Autologous Hematopoietic Cell Transplantation for Lymphoma

artículo científico publicado en 2016

Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation.

artículo científico publicado en 2007

Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation

artículo científico publicado en 2014

Comparable outcomes after nonmyeloablative hematopoietic cell transplantation with unrelated and related donors

artículo científico publicado en 2007

Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities

artículo científico publicado en 2004

Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation

artículo científico publicado en 2005

Comparison of lung function after myeloablative and 2 Gy of total body irradiation-based regimens for hematopoietic stem cell transplantation

artículo científico publicado en 2005

Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma

artículo científico publicado en 2008

Continued Excellent Outcomes in Previously Untreated Patients With Follicular Lymphoma After Treatment With CHOP Plus Rituximab or CHOP Plus 131I-Tositumomab: Long-Term Follow-Up of Phase III Randomized Study SWOG-S0016.

artículo científico publicado en 2018

Cooperative epigenetic modulation by cancer amplicon genes

artículo científico publicado en 2010

Cytopenias after day 28 in allogeneic hematopoietic cell transplantation: impact of recipient/donor factors, transplant conditions and myelotoxic drugs ⬇️

artículo científico publicado el 31 de agosto de 2011

Decreased Serum Albumin as a Biomarker for Severe Acute Graft-versus-Host Disease after Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation ⬇️

artículo científico publicado el 30 de julio de 2011

Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemia

scientific article published on 30 June 2009

Diversity in antibody-based approaches to non-Hodgkin lymphoma ⬇️

artículo científico publicado el 1 de agosto de 2010

Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation: prognostic relevance of the initial CD3+ T cell dose

artículo científico publicado en 2013

Donor statin treatment protects against severe acute graft-versus-host disease after related allogeneic hematopoietic cell transplantation

artículo científico publicado en 2009

Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor-Modified T Cells After Failure of Ibrutinib

artículo científico publicado en 2017

Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation

artículo científico publicado en 2014

Early recovery of CD4 T cell receptor diversity after "lymphoablative" conditioning and autologous CD34 cell transplantation

artículo científico publicado en 2008

Effect of conditioning regimen intensity on CMV infection in allogeneic hematopoietic cell transplantation

artículo científico publicado en 2009

Effect of remission status and induction chemotherapy regimen on outcome of autologous stem cell transplantation for mantle cell lymphoma

artículo científico publicado en 2008

Engraftment of early erythroid progenitors is not delayed after non-myeloablative major ABO-incompatible haematopoietic stem cell transplantation

artículo científico publicado en 2002

Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning

artículo científico publicado en 2007

Factors affecting antibody levels after allogeneic hematopoietic cell transplantation

artículo científico publicado en 2002

Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy

artículo científico publicado en 2019

Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation

scientific article published on 08 August 2006

Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone ⬇️

artículo científico publicado el 22 de enero de 2012

Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

artículo científico publicado en 2008

Fludarabine and 2-Gy TBI is superior to 2 Gy TBI as conditioning for HLA-matched related hematopoietic cell transplantation: a phase III randomized trial

artículo científico publicado en 2013

Follicular NHL: from antibodies and vaccines to graft-versus-lymphoma effects

artículo científico publicado en 2007

Glucocorticoids and rituximab in vitro: synergistic direct antiproliferative and apoptotic effects.

artículo científico publicado en 2002

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation

artículo científico publicado en 2003

Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation

artículo científico publicado en 2013

Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

artículo científico publicado en 2005

Graft-vs.-lymphoma effect in various histologies of non-Hodgkin's lymphoma

artículo científico publicado en 2003

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid leukemia

artículo científico publicado en 2005

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

artículo científico publicado en 2003

Heavy/light chain ratio normalization prior to transplant is of independent prognostic significance in multiple myeloma: a BMT CTN 0102 correlative study

artículo científico publicado en 2016

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

artículo científico publicado en 2005

Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia

artículo científico publicado en 2005

Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences

artículo científico publicado en 2007

Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation

artículo científico publicado en 2008

Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients

artículo científico publicado en 2003

High-dose CD20-targeted radioimmunotherapy-based autologous transplantation improves outcomes for persistent mantle cell lymphoma

artículo científico publicado en 2015

High-dose [131I]tositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults > or = 60 years old with relapsed or refractory B-cell lymphoma.

artículo científico publicado en 2007

High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma

artículo científico publicado en 2002

High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysis.

artículo científico publicado en 2003

High-dose therapy and autologous stem cell transplantation for chemoresistant Hodgkin lymphoma: the Seattle experience

artículo científico publicado en 2008

High-throughput identification of promiscuous inhibitors from screening libraries with the use of a thiol-containing fluorescent probe

artículo científico publicado en 2013

Histology and time to progression predict survival for lymphoma recurring after reduced-intensity conditioning and allogeneic hematopoietic cell transplantation

artículo científico publicado en 2011

Hodgkin lymphoma

artículo científico publicado en 2011

Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines.

artículo científico publicado en 2012

Hodgkin lymphoma, version 2.2015.

artículo científico publicado en 2015

Identification of MAGE-C1 (CT-7) epitopes for T-cell therapy of multiple myeloma

artículo científico

Immune reconstitution after anti-thymocyte globulin-conditioned hematopoietic cell transplantation ⬇️

artículo científico publicado el 18 de septiembre de 2012

Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning ⬇️

artículo científico publicado el 1 de octubre de 2003

Immunotherapy for non-Hodgkin's lymphoma: monoclonal antibodies and vaccines

artículo científico publicado en 2005

Immunotherapy of non-Hodgkin's lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells

artículo científico publicado en 2016

Immunotherapy with rituximab/interleukin-2 after autologous stem cell transplantation as treatment for CD20+ non-Hodgkin's lymphoma.

artículo científico publicado en 2006

Impact of donor age on outcome after allogeneic hematopoietic cell transplantation

artículo científico publicado en 2014

Impact of pretransplantation conditioning regimens on outcomes of allogeneic transplantation for chemotherapy-unresponsive diffuse large B cell lymphoma and grade III follicular lymphoma

artículo científico publicado en 2013

Impact of recipient statin treatment on graft-versus-host disease after allogeneic hematopoietic cell transplantation ⬇️

artículo científico publicado el 26 de mayo de 2010

Impact of unrelated donor status on the incidence and outcome of cytomegalovirus infections after non-myeloablative allogeneic stem cell transplantation

artículo científico publicado en 2003

Improving the efficacy of reduced intensity allogeneic transplantation for lymphoma using radioimmunotherapy

artículo científico publicado en 2006

Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study

artículo científico publicado en 2002

Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study

artículo científico publicado en 2002

Indolent lymphomas: current and emerging treatment approaches

artículo científico publicado en 2006

Infectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapy

artículo científico publicado en 2017

Inhibition of DNA glycosylases via small molecule purine analogs

artículo científico publicado en 2013

Interleukin-7 improves CD4 T-cell reconstitution after autologous CD34 cell transplantation in monkeys

artículo científico publicado en 2003

Interleukin-7 improves reconstitution of antiviral CD4 T cells

artículo científico publicado en 2005

Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy.

artículo científico publicado en 2017

Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

artículo científico publicado en 2004

Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma

scholarly article by Enrico Maffini et al published February 2019 in Haematologica

Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting

artículo científico publicado en 2008

Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies

artículo científico publicado en 2011

Long-term outcomes of patients with persistent indolent B cell malignancies undergoing nonmyeloablative allogeneic transplantation

artículo científico publicado en 2014

Long-term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

artículo científico publicado en 2015

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induc

artículo científico publicado en 2002

Low-dose total body irradiation and fludarabine conditioning for HLA class I-mismatched donor stem cell transplantation and immunologic recovery in patients with hematologic malignancies: a multicenter trial

artículo científico publicado en 2009

Management of cytokine release syndrome and neurotoxicity in chimeric antigen receptor (CAR) T cell therapy

scientific article published on 18 March 2019

Mantle Cell Lymphoma International Prognostic Index but Not Pretransplantation Induction Regimen Predicts Survival for Patients With Mantle-Cell Lymphoma Receiving High-Dose Therapy and Autologous Stem-Cell Transplantation ⬇️

artículo científico publicado el 5 de julio de 2011

Modified total body irradiation as a planned second high-dose therapy with stem cell infusion for patients with bone-based malignancies.

artículo científico publicado en 2005

Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors

artículo científico publicado en 2004

Multi-centre validation of the prognostic value of the haematopoietic cell transplantation- specific comorbidity index among recipient of allogeneic haematopoietic cell transplantation

artículo científico publicado en 2015

Myeloablative I-131-tositumomab with escalating doses of fludarabine and autologous hematopoietic transplantation for adults age ≥ 60 years with B cell lymphoma

artículo científico publicado en 2014

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantatio

artículo científico publicado en 2010

New treatment options have changed the survival of patients with follicular lymphoma

artículo científico publicado en 2005

Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience

artículo científico publicado en 2008

Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission

artículo científico publicado en 2003

Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia ⬇️

artículo científico publicado el 20 de abril de 2011

Non-myeloablative transplantation.

artículo científico publicado en 2002

Nonmyeloablative allogeneic hematopoietic cell transplantation for relapsed or refractory Waldenstrom macroglobulinemia: Evidence for a graft-versus-lymphoma effect.

artículo científico publicado en 2018

Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia

artículo científico publicado en 2010

Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma

artículo científico publicado en 2007

Nonmyeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di Midollo

artículo científico publicado en 2008

Nonmyeloablative hematopoietic cell transplantation: status quo and future perspectives

artículo científico publicado en 2002

Nonmyeloablative unrelated donor hematopoietic cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myeloma

artículo científico publicado en 2007

Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia

artículo científico publicado en 2007

Peroxisome proliferation-activated receptor δ agonist GW0742 interacts weakly with multiple nuclear receptors, including the vitamin D receptor

scientific article published on 10 June 2013

Phase II trial of CHOP chemotherapy followed by tositumomab/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: five-year follow-up of Southwest Oncology Group Protocol S9911.

artículo científico publicado en 2006

Polymorphisms in FcgammaRIIIA (CD16) receptor expression are associated with clinical response to rituximab in Waldenström's macroglobulinemia

artículo científico publicado en 2005

Pre-transplant comorbidity burden and post-transplant chronic graft-versus-host disease

artículo científico publicado en 2015

Predictors of cytopenias after treatment with axicabtagene ciloleucel in patients with large B-cell lymphoma

artículo científico publicado en 2022

Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality.

artículo científico publicado en 2014

Pretransplantation Minimal Residual Disease Predicts Survival in Patients with Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission

artículo científico publicado en 2015

Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantation

artículo científico publicado en 2005

Radioimmunotherapy consolidation using 131I-tositumomab for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma in first remission

artículo científico publicado en 2015

Radiolabeled anti-CD45 antibody with reduced-intensity conditioning and allogeneic transplantation for younger patients with advanced acute myeloid leukemia or myelodysplastic syndrome

artículo científico publicado en 2014

Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases).

artículo científico publicado en 2004

Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders

artículo científico publicado en 2008

Relapse or progression after hematopoietic cell transplantation using nonmyeloablative conditioning: effect of interventions on outcome ⬇️

artículo científico publicado el 1 de octubre de 2003

Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

artículo científico publicado en 2007

Reversal of Low Donor Chimerism after Hematopoietic Cell Transplantation Using Pentostatin and Donor Lymphocyte Infusion: A Prospective Phase II Multicenter Trial

artículo científico publicado en 2017

Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation

scientific article published on 10 July 2003

Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning ⬇️

artículo científico publicado el 10 de abril de 2003

Rituximab for follicular lymphoma.

artículo científico publicado en 2003

Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience

artículo científico publicado en 2017

Rituximab resistance ⬇️

artículo científico publicado el 13 de abril de 2011

Rituximab-based allogeneic transplant for chronic lymphocytic leukemia with comparison to historical experience

scientific article published on 03 September 2019

Rituximab: mechanism of action and resistance

artículo científico publicado en 2002

Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts

artículo científico publicado en 2009

Specific features identify patients with relapsed or refractory mantle cell lymphoma benefitting from autologous hematopoietic cell transplantation

artículo científico publicado en 2013

Stem cell transplantation for indolent lymphoma and chronic lymphocytic leukemia

artículo científico publicado en 2011

Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myeloma

scientific article published on 09 November 2017

The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen

artículo científico publicado en 2015

The impact of donor type and ABO incompatibility on transfusion requirements after nonmyeloablative haematopoietic cell transplantation

artículo científico publicado en 2010

The pretransplant Follicular Lymphoma International Prognostic Index is associated with survival of follicular lymphoma patients undergoing autologous hematopoietic stem cell transplantation

artículo científico publicado en 2007

The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells

scientific article published on 19 February 2019

Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'.

artículo científico publicado en 2018

Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors

artículo científico publicado en 2005

Treatment of follicular non-Hodgkin's lymphoma

artículo científico publicado en 2005

Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus

artículo científico publicado en 2014

Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing

artículo científico publicado en 2006

Unrelated donor status and high donor age independently affect immunologic recovery after nonmyeloablative conditioning.

artículo científico publicado en 2006

Update on recommendations for assessing response from the Third International Workshop on Waldenstrom's Macroglobulinemia

artículo científico publicado en 2006

Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia

artículo científico publicado en 2006

What is the role for donor natural killer cells after nonmyeloablative conditioning?

scientific article published on May 2009

What is the role of maintenance rituximab in follicular NHL?

artículo científico publicado en 2008

⁹⁰Y-Ibritumomab tiuxetan, fludarabine, and TBI-based nonmyeloablative allogeneic transplantation conditioning for patients with persistent high-risk B-cell lymphoma

artículo científico publicado en 2011

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda